Commonly reported side effects of peginterferon beta-1a include: arthralgia, asthenia, fever, flu-like symptoms, headache, myalgia, chills, erythema at injection site, pain at injection site, and swelling at injection site. Other side effects include: suicidal ideation, hyperthermia, increased serum alanine aminotransferase, pruritus, vomiting, decreased white blood cell count, depression, increased serum aspartate aminotransferase, and increased body temperature.  See below for a comprehensive list of adverse effects.
Applies to peginterferon beta-1a: subcutaneous solution
As well as its needed effects, peginterferon beta-1a may cause unwanted side effects that require medical attention. 
If any of the following side effects occur while taking peginterferon beta-1a, check with your doctor immediately:
Some peginterferon beta-1a side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:


Applies to peginterferon beta-1a: subcutaneous kit, subcutaneous solution
Frequency not reported: Congestive heart failure[Ref]
Common (1% to 10%): Pruritus[Ref]
Common (1% to 10%): Nausea, vomiting[Ref]
The most common side effects were injection site erythema, influenza-like illness, pyrexia, headache, myalgia, chills, injection site pain, asthenia, injection site pruritus, and arthralgia.The most commonly reported adverse event leading to discontinuation was influenza-like illness (in less than 1% of patients).[Ref]
Frequency not reported: Decreased peripheral blood counts[Ref]
Common (1% to 10%): Increased ALT, increased AST, increased GGT (gamma-glutamyl-transferase)Frequency not reported: hepatic injury[Ref]
Frequency not reported: Anaphylaxis allergic reactions[Ref]
Frequency not reported: Autoimmune disorders[Ref]
Very common (10% or more): Injection site erythema (up to 62%), influenza like illness (up to 47%), pyrexia (up to 45%), chills (up to 17%), injection site pain (up to 15%), injection site pruritus (up to 13%)Common (1% to 10%): Injection site edema, injection site warmth, injection site hematoma, injection site rash[Ref]
Very common (10% or more): Myalgia (up to 19%), arthralgia (up to 11%)[Ref]
Very common (10% or more): Headache (up to 44%)Frequency not reported: Seizures[Ref]
Very common: Asthenia (13%)Common (1% to 10%): Increased body temperature, hyperthermia, pain[Ref]
Frequency not reported: Depression, suicide[Ref]
1. "Product Information. Plegridy (peginterferon beta-1a)." Biogen Idec Inc, Cambridge, MA. 
It is possible that some side effects of peginterferon beta-1a may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.

Blue-green to black skin discoloration
chills
cough or sore throat
diarrhea
dizziness
extremely high fever or body temperature
fast, shallow breathing
fast, weak heartbeat
fever
general feeling of discomfort or illness
joint pain
muscle aches and pains
muscle cramps
pale, clammy skin
runny nose
shivering
sweating
thirst
trouble sleeping
unusual tiredness or weakness
vomiting


Dark urine
decreased appetite
general feeling of tiredness or weakness
itching skin
light-colored stools
stomach or abdominal pain
yellow eyes or skin


Difficulty with swallowing
hives or welts
large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
redness of the skin
skin rash
tightness in the chest


Difficulty with moving
itching, rash, redness, soreness, swelling, or warmth at the injection site
lack or loss of strength
muscle stiffness
pain, redness, or sloughing of skin at the injection site

